Skip to main content

Table 1 Clinical and metabolic parameters in patients with IDM and NIDM at diagnosis

From: Non-immune-mediated versus immune-mediated type 1 diabetes: diagnosis and long-term differences—retrospective analysis

  IDM group
(n = 29; 78.4%)
Mean ± SD
Median (IQR)
NIDM group
(n = 8; 21.6%)
Mean ± SD
Median (IQR)
p value
Clinical parameters
 Age (years) 23.0 (9) 38.1 ± 12.8 0.004*
 BMI (Kg/m2) 20.97 (3.5) 20.37 ± 2.7 0.435
 Family history type 1/2 DM (%) 17.2/37.9 12.5/37.5 0.999
 Symptoms duration (days) 21.8 ± 8.8 45.0 (60) 0.003*
 Presentation of the disease    0.744
 Arterial hypertension (%) 6.9 0 0.999
Metabolic parameters
 Plasma glucose at admission (mmol/L) 25.47 (8.16) 23.92 (8.66) 0.482
 HbA1c (%) 11.3 ± 2.2 11.8 (2.5) 0.794
 TDID (U) 46.4 ± 15.3 40.1 ± 12.3 0.301
 Dyslipidemia (%) 24.1 25.0 0.999
 Total-C (mmol/L) 8.77 (2.61) 9.05 (2.72) 0.585
 LDL-C (mmol/L) 5.57 ± 1.44 5.90 ± 1.47 0.579
 HDL-C (mmol/L) 2.75 ± 0.83 2.80 (0.50) 0.833
 Triglycerides (mmol/L) 4.73 (1.37) 3.72 (2.05) 0.555
  1. SD: standard deviation; IQR: interquartile range
  2. p* < 0.05: statistically significant difference
  3. Presentation of the disease: diabetic ketoacidosis; hyperglycemic hyperosmolar syndrome; polyuric polydipsic syndrome; diabetic ketoacidosis with hyperosmolarity; seizures